Zacks Investment Research Upgrades Mettler-Toledo International (MTD) to “Buy”

Mettler-Toledo International (NYSE:MTD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday. The firm currently has a $640.00 price objective on the medical instruments supplier’s stock. Zacks Investment Research‘s target price points to a potential upside of 12.33% from the company’s current price.

According to Zacks, “Mettler-Toledo is benefiting from strong product pipeline. The acquisition of Biotix is helping the company gain access to indirect distribution channels with robust secondary brands. We remain positive about Mettler-Toledo’s leading market position, focus on product development and cost reduction, sales and marketing efforts and operational excellence programs. The company is expected to benefit from strong growth prospects in product inspection and services. Estimates have been stable lately ahead of the company’s Q4 earnings release. The company has a positive record of earnings surprises in recent quarters. However, seasonality, volatility in emerging market growth, foreign exchange risk and business concentration in China remain overhangs. In past one year, the stock has slightly underperformed the industry it belongs.”

A number of other analysts also recently issued reports on MTD. Morgan Stanley cut their price objective on Mettler-Toledo International from $595.00 to $568.00 and set an “equal weight” rating for the company in a research report on Wednesday. Goldman Sachs downgraded Mettler-Toledo International from a “buy” rating to a “neutral” rating in a research report on Monday. Deutsche Bank raised their price objective on Mettler-Toledo International from $600.00 to $630.00 and gave the stock a “hold” rating in a research report on Thursday, March 1st. Robert W. Baird cut their price objective on Mettler-Toledo International from $675.00 to $630.00 and set a “neutral” rating for the company in a research report on Friday, February 9th. Finally, Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $685.00 to $692.00 in a research report on Friday, February 9th. Seven research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $641.00.



Shares of NYSE:MTD opened at $569.76 on Wednesday. The company has a debt-to-equity ratio of 1.75, a current ratio of 1.46 and a quick ratio of 1.09. The stock has a market cap of $14,396.48, a P/E ratio of 32.13, a price-to-earnings-growth ratio of 2.21 and a beta of 1.20. Mettler-Toledo International has a 12-month low of $472.44 and a 12-month high of $697.26.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 8th. The medical instruments supplier reported $5.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.93 by $0.04. The firm had revenue of $778.03 million during the quarter, compared to the consensus estimate of $764.26 million. Mettler-Toledo International had a return on equity of 94.54% and a net margin of 13.80%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the company earned $5.28 EPS. sell-side analysts forecast that Mettler-Toledo International will post 20.24 EPS for the current year.

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 3,000 shares of Mettler-Toledo International stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $640.00, for a total value of $1,920,000.00. Following the completion of the transaction, the insider now directly owns 3,000 shares of the company’s stock, valued at approximately $1,920,000. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $605.20, for a total value of $181,560.00. Following the completion of the transaction, the chief financial officer now directly owns 5,599 shares of the company’s stock, valued at $3,388,514.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,268 shares of company stock valued at $17,497,059. 4.80% of the stock is currently owned by corporate insiders.

Institutional investors have recently made changes to their positions in the company. IFM Investors Pty Ltd grew its position in shares of Mettler-Toledo International by 44.1% during the fourth quarter. IFM Investors Pty Ltd now owns 546 shares of the medical instruments supplier’s stock worth $338,000 after buying an additional 167 shares in the last quarter. Martingale Asset Management L P grew its position in shares of Mettler-Toledo International by 18.0% during the fourth quarter. Martingale Asset Management L P now owns 18,734 shares of the medical instruments supplier’s stock worth $11,607,000 after buying an additional 2,860 shares in the last quarter. BlackRock Inc. grew its position in shares of Mettler-Toledo International by 2.3% during the fourth quarter. BlackRock Inc. now owns 1,847,591 shares of the medical instruments supplier’s stock worth $1,144,617,000 after buying an additional 41,344 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Mettler-Toledo International by 9.7% during the fourth quarter. Wells Fargo & Company MN now owns 33,286 shares of the medical instruments supplier’s stock worth $20,622,000 after buying an additional 2,950 shares in the last quarter. Finally, California Public Employees Retirement System grew its position in shares of Mettler-Toledo International by 6.3% during the third quarter. California Public Employees Retirement System now owns 75,445 shares of the medical instruments supplier’s stock worth $47,241,000 after buying an additional 4,445 shares in the last quarter. 92.45% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Zacks Investment Research Upgrades Mettler-Toledo International (MTD) to “Buy”” was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://dakotafinancialnews.com/2018/04/13/zacks-investment-research-upgrades-mettler-toledo-international-mtd-to-buy.html.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Get a free copy of the Zacks research report on Mettler-Toledo International (MTD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply